Lina Ma

449 total citations
23 papers, 293 citations indexed

About

Lina Ma is a scholar working on Ophthalmology, Rheumatology and Genetics. According to data from OpenAlex, Lina Ma has authored 23 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 10 papers in Rheumatology and 6 papers in Genetics. Recurrent topics in Lina Ma's work include Ocular Diseases and Behçet’s Syndrome (12 papers), Autoimmune Bullous Skin Diseases (5 papers) and Urticaria and Related Conditions (5 papers). Lina Ma is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (12 papers), Autoimmune Bullous Skin Diseases (5 papers) and Urticaria and Related Conditions (5 papers). Lina Ma collaborates with scholars based in United States, China and Argentina. Lina Ma's co-authors include C. Stephen Foster, Caiyun You, Andrés F. Lasave, Arash Maleki, Frederick A. Jakobiec, Thaddeus P. Dryja, Stephen D. Anesi, Halea Meese, Stephen C. Foster and Andrew Stephenson and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Lina Ma

23 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lina Ma United States 10 192 102 67 52 40 23 293
Pichaporn Artornsombudh United States 11 247 1.3× 88 0.9× 46 0.7× 27 0.5× 28 0.7× 15 307
Arash Maleki United States 11 370 1.9× 83 0.8× 49 0.7× 18 0.3× 12 0.3× 50 423
Susan Lightman United Kingdom 8 247 1.3× 123 1.2× 123 1.8× 11 0.2× 29 0.7× 12 384
Nicole Stuebiger Germany 13 403 2.1× 160 1.6× 67 1.0× 18 0.3× 13 0.3× 25 448
Éric Fortin United States 5 143 0.7× 87 0.9× 29 0.4× 38 0.7× 8 0.2× 12 247
Priyanka Doctor United States 12 350 1.8× 124 1.2× 111 1.7× 16 0.3× 17 0.4× 15 461
Kimberly Baynes United States 11 366 1.9× 46 0.5× 28 0.4× 23 0.4× 8 0.2× 39 411
Fabrizio Gozzi Italy 8 207 1.1× 35 0.3× 33 0.5× 16 0.3× 7 0.2× 24 246
Miguel Pedroza-Seres United States 10 313 1.6× 94 0.9× 60 0.9× 12 0.2× 4 0.1× 33 414
P. Fanlo Spain 7 97 0.5× 95 0.9× 66 1.0× 8 0.2× 19 0.5× 37 188

Countries citing papers authored by Lina Ma

Since Specialization
Citations

This map shows the geographic impact of Lina Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Ma more than expected).

Fields of papers citing papers by Lina Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Ma. The network helps show where Lina Ma may publish in the future.

Co-authorship network of co-authors of Lina Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Ma. A scholar is included among the top collaborators of Lina Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Ma. Lina Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Lina, Travis Sullivan, Kimberly Rieger‐Christ, et al.. (2023). Vascular invasion predicts the subgroup of lung adenocarcinomas ≤2.0 cm at risk of poor outcome treated by wedge resection compared to lobectomy. JTCVS Open. 16. 938–947. 6 indexed citations
3.
Ma, Lina, Frederick A. Jakobiec, & Thaddeus P. Dryja. (2019). A Review of Next-Generation Sequencing (NGS): Applications to the Diagnosis of Ocular Infectious Diseases. Seminars in Ophthalmology. 34(4). 223–231. 29 indexed citations
4.
You, Caiyun, et al.. (2019). Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for Birdshot Retinochoroidopathy. Ocular Immunology and Inflammation. 28(6). 966–974. 9 indexed citations
5.
Ma, Lina, Natalie Wolkow, & Frederick A. Jakobiec. (2018). Choroidal Mucinous Metastatic Adenocarcinoma from the Colon: A Diagnostic Challenge. Ocular Oncology and Pathology. 5(1). 66–74. 2 indexed citations
6.
Ma, Lina, Frederick A. Jakobiec, Natalie Wolkow, Thaddeus P. Dryja, & Gary E. Borodic. (2018). Multiple Eyelid Cysts (Apocrine and Eccrine Hidrocystomas, Trichilemmal Cyst, and Hybrid Cyst) in a Patient With a Prolactinoma. Ophthalmic Plastic and Reconstructive Surgery. 34(3). e83–e85. 2 indexed citations
7.
Ma, Lina, Caiyun You, Arash Maleki, et al.. (2018). Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy. Ocular Immunology and Inflammation. 27(4). 636–642. 9 indexed citations
8.
You, Caiyun, Lina Ma, & Stephen D. Anesi. (2018). Bilateral papillitis and vitritis as the initial ophthalmologic finding in a patient with complex medical history, leading to diagnosis of multisystem sarcoidosis. American Journal of Ophthalmology Case Reports. 13. 122–126. 1 indexed citations
9.
You, Caiyun, et al.. (2018). Outcomes of “Early” Withdrawal of Corticosteroid Sparing Immunomodulatory Therapy for Birdshot Retinochoroidopathy. Ocular Immunology and Inflammation. 27(7). 1165–1173. 3 indexed citations
10.
Anesi, Stephen D., et al.. (2017). Characteristics and Visual Outcome of Refractory Retinal Vasculitis Associated With Antineutrophil Cytoplasm Antibody–Associated Vasculitides. American Journal of Ophthalmology. 187. 21–33. 13 indexed citations
11.
You, Caiyun, et al.. (2017). Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(6). 1221–1228. 27 indexed citations
12.
Maleki, Arash, et al.. (2017). Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy. Clinical ophthalmology. Volume 11. 377–385. 19 indexed citations
13.
You, Caiyun, Lina Ma, Stephen D. Anesi, & C. Stephen Foster. (2017). Long-term remission of ocular cicatricial pemphigoid off immunomodulatory therapy. European Journal of Ophthalmology. 28(2). 157–162. 10 indexed citations
14.
You, Caiyun, et al.. (2017). A review and update on orphan drugs for the treatment of noninfectious uveitis. Clinical ophthalmology. Volume 11. 257–265. 28 indexed citations
16.
You, Caiyun, Lina Ma, Andrés F. Lasave, & C. Stephen Foster. (2017). Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener’s). Ocular Immunology and Inflammation. 26(8). 1166–1173. 33 indexed citations
17.
You, Caiyun, Lina Ma, Stephen D. Anesi, & C. Stephen Foster. (2016). Long-term Complete Remission of Ocular Cicatricial Pemphigoid off Immunomodulatory Therapy. Investigative Ophthalmology & Visual Science. 57(12). 504–504. 6 indexed citations
18.
Maleki, Arash, et al.. (2016). Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma. Ophthalmology. 123(12). 2630–2632. 28 indexed citations
19.
20.
Li, Ping, et al.. (2008). [Thyroid follicular carcinoma-like tumor of kidney: report of a case ].. PubMed. 37(6). 428–30. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026